CHTP Stock – Chelsea Therapeutics Passes FDA Test, Stock Skyrockets

An FDA advisory panel reportedly voted to support a drug from Chelsea Therapeutics, sending CHTP stock soaring. More 

ICPT: Time to Catch a Rising Star With Intercept Stock?

It's never too late to invest in a long-term winner, and pharmaceutical player Intercept is on a long-term run. Here's why you should join the race... More 

ACT: Actavis’s Growth Potential Anything But Generic

Pharmaceutical company Actavis is at the forefront on the production of biologic drugs, and stands to profit from them well into the future. It's a buy! More 

ICPT – Why Intercept Pharmaceuticals Just Exploded

Intercept Pharmaceuticals says a trial of its liver drug was halted early after the drug met its primary goal, sending ICPT stock up more than 280% on Thursday. More 

Sequenom – SQNM Stock Soars on Genetic Testing Patent

Shares of Sequenom climbed almost 9% on Thursday after the company said it had been awarded a European patent for a genetic testing process. More 

GSK Stock Inches Higher on Accelerated FDA Approval

GlaxoSmithKline said that the FDA had approve a combination of two drugs to treat melanoma, sending GSK stock up modestly on Thursday. More 

OXBT Stock – Why Oxygen Biotherapeutics Boomed Over 30%

Oxygen Biotherapeutics has published the protocols for a phase 3 trial of its new cardiac drug, sending OXBT stock up sharply. More